Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, researchers are using the same tactics to advance prostate cancer treatment.

Stage 2 prostate adenocarcinoma is localized, with a nearly 100% five-year relative survival rate. Diagnosis uses the TNM system, PSA levels, and Gleason score to determine cancer stage and risk.

Doctors began testing PSA levels in the 1980s to monitor diagnosed cancers. By the early 1990s, researchers promoted it for ...

The PROSTaid group, which meets monthly at The Cradock Arms in Leicester, aims to create a support group for men so they can ...

Thousands of men battling prostate cancer are set to gain access to a life-extending drug on the NHS following a significant ...

The myth is that prostate cancer treatment destroys men’s erections. The truth is more complicated. Men facing treatment for this disease should prepare themselves emotionally for permanent erectile ...

If a person has an “aggressive” prostate cancer with a Gleason score of 9, what does that mean? What’s the outlook when it comes to survival rate and prognosis? Every cancer survivor is unique, of ...

NHS England has announced that men whose high-risk prostate cancer has not yet spread will be able to receive the drug, ...